Nucleic Acid Isolation and Purification Market Size, Share, Growth, Trends and Forecast Report

by Susan Hill Business Consultant

The global nucleic acid isolation and purification market size is expected to reach USD 4.2 billion by 2027, growing at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research, Inc. Nucleic acid isolation is the most basic step deployed in sequencing technologies. Increasing employment of next-generation sequencing (NGS) techniques along with the declining cost of genomic sequencing drives the market.

Ongoing developments of automated nucleic acid extraction systems designed for high-throughput sample processing have significantly simplified the isolation of DNA and RNA, thereby providing lucrative avenues for market growth. These systems potentially reduce the labor costs and time, increase worker safety, laboratory efficiency, reproducibility, and quality of results.

The growing popularity of biopharmaceuticals has led to the development of nucleic acid-based products, such as DNA vaccines, small interfering RNA, and antisense oligonucleotides. These products are applied in therapeutic techniques, such as gene therapy and anti-sense technology, as a powerful tool for medical practitioners to treat cancer, genetic, and infectious diseases. This has boosted the adoption of DNA or RNA isolation techniques in the market.

Further key findings from the report suggest:

The instruments segment is expected to grow at a lucrative pace due to the advent of automated extraction systems resulting in high performance and lower cost for DNA extraction
DNA isolation methods accounted for the largest revenue share and are anticipated to witness the fastest progress rate due to ongoing discoveries of simple, rapid, and inexpensive methods
The high adoption rate of magnetic bead methods is attributive to its largest revenue share
This is because the method can isolate nucleic acids directly from the crude sample without much processing
This method is also expected to witness the fastest CAGR owing to the development of functionalized magnetic particles that have been incorporated in buffer systems to provide rapid and efficient extraction
Oncology application is projected to witness a lucrative growth rate as liquid biopsy techniques and patient-tailored therapies are gaining traction for cancer diagnosis
Hospitals and diagnostic centers accounted for the largest share in 2019, in terms of revenue
The high incidence rate of genetic and inherited diseases has increased the usage of nucleic acid isolation in early and accurate diagnosis of these conditions in hospitals
Better healthcare infrastructure, a substantial number of technology providers, and rapid adoption of NGS has driven the uptake of nucleic acid extraction products in North America at a large scale
Asia Pacific is anticipated to exhibit the fastest CAGR over the forecast period owing to significant public and private commitments towards genomics research and precision medicine, thereby prompting the adoption of isolation techniques
QIAGEN, Agilent Technologies, Danaher, Illumina, Roche, and Thermo Fisher are some key companies operating in the nucleic acid isolation and purification market.